This study compares the medium-term effects of surgical and medical abortion on sexual function in women who have experienced early pregnancy loss (6-12 weeks gestation). A total of 86 women (45 medical abortion, 41 surgical abortion) were followed for 6 months. Sexual function was measured using the Female Sexual Function Index (FSFI) before treatment and at 6 months after the procedure. The surgical abortion group showed a significant decline in total FSFI score at 6 months compared to baseline, with decreases observed in all six domains: desire, arousal, lubrication, orgasm, satisfaction, and pain. The medical abortion group showed no significant change in total FSFI score. Between-group comparison at 6 months revealed significantly lower total FSFI scores in the surgical group compared to the medical group. These findings suggest that surgical abortion for early pregnancy loss is associated with a significant decline in sexual function that persists up to 6 months after the procedure, whereas medical abortion appears to have a neutral effect during the same period. Due to the non-randomized design, these findings should be considered hypothesis-generating.
This prospective, comparative cohort study was conducted at Harran University Faculty of Medicine between April 2025 and January 2026. Women aged 18-40 diagnosed with early pregnancy loss (6-12 weeks gestation) were allocated to surgical or medical abortion based on shared decision-making. The Female Sexual Function Index (FSFI) was used to evaluate sexual function before treatment and at 6 months follow-up. Statistical analyses were performed using non-parametric tests (Mann-Whitney U, Wilcoxon signed-rank) with Bonferroni correction. Effect sizes (r) were calculated for all primary outcomes.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
88
Participants received 200 mg oral mifepristone under supervision at the clinic, followed by 800 µg misoprostol administered at home 24-48 hours later.
Participants underwent vacuum aspiration under local or general anesthesia in an operating room for early pregnancy loss at 6-12 weeks gestation.
Harran University, Department of Gynecology and Obstetrics
Sanliurfa, Şanliurfa, Turkey (Türkiye)
Change in Female Sexual Function Index (FSFI) Total Score
The FSFI is a 19-item, multidimensional self-report questionnaire assessing female sexual function over the past four weeks. It evaluates six domains: desire, arousal, lubrication, orgasm, satisfaction, and pain. The total score is the sum of six domain scores (range 2-36). Lower scores indicate worse sexual dysfunction. A total score of ≤26.55 is the validated cutoff for female sexual dysfunction.
Time frame: Baseline (pre-treatment) and 6 months post-abortion procedure
Change in FSFI - Desire Domain Score
Desire domain consists of 2 items assessing sexual desire and interest over the past 4 weeks. Domain score range: 1.2-6.0.
Time frame: Baseline and 6 months
Change in FSFI - Arousal Domain Score
Arousal domain consists of 4 items assessing sexual excitement and arousal over the past 4 weeks. Domain score range: 0-6.0.
Time frame: Baseline and 6 months
Change in FSFI - Orgasm Domain Score
Orgasm domain consists of 3 items assessing ability to achieve orgasm over the past 4 weeks. Domain score range: 0-6.0.
Time frame: Baseline and 6 months
Change in FSFI - Lubrication Domain Score
Lubrication domain consists of 4 items assessing vaginal lubrication during sexual activity over the past 4 weeks. Domain score range: 0-6.0.
Time frame: Baseline and 6 months
Change in FSFI - Pain Domain Score
Pain domain consists of 3 items assessing pain during vaginal penetration and sexual activity over the past 4 weeks. Domain score range: 0-6.0.
Time frame: Baseline and 6 months
Change in FSFI - Satisfaction Domain Score
Satisfaction domain consists of 3 items assessing sexual satisfaction over the past 4 weeks. Domain score range: 0.8-6.0.
Time frame: Baseline and 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.